Info
- Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.
Clinical Dilemmas in Inflammatory Bowel Disease [[electronic resource] ] : New Challenges
| Clinical Dilemmas in Inflammatory Bowel Disease [[electronic resource] ] : New Challenges |
| Autore | Irving Peter |
| Edizione | [2nd ed.] |
| Pubbl/distr/stampa | Hoboken, : Wiley, 2011 |
| Descrizione fisica | 1 online resource (286 p.) |
| Disciplina | 616.344 |
| Altri autori (Persone) |
SiegelCorey A
RamptonDavid ShanahanFergus |
| Soggetto topico |
Clinical dilemmas
Inflammatory bowel diseases Inflammatory Bowel Diseases Inflammatory bowel diseases - Decision making Inflammatory bowel diseases -- Decision making Intestinal Diseases Gastroenteritis Gastrointestinal Diseases Digestive System Diseases Diseases Medicine Health & Biological Sciences Gastroenterology |
| ISBN |
1-283-24049-1
9786613240491 1-4443-4257-6 1-4443-4254-1 |
| Formato | Materiale a stampa  |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Clinical Dilemmas inInflammatoryBowel Disease; Contents; Contributors; Preface; Part I: Genes and Phenotype in IBD; 1 Which will take us further in IBD-study of coding variation or epigenetics?; 2 IBD in different ethnic groups: same or different?; Part II: Bugs and IBD-Good, Bad, or Indifferent?; 3 How does the risk of infection influence management of IBD around the world?; 4 Traveling with IBD; 5 What to do about hepatitis B and hepatitis C in patients with IBD; 6 CMV in IBD-passenger or pathogen?; 7 Clostridium difficile in IBD: impact, prevention, and treatment
8 Prebiotics and synbiotics: panacea or placebo9 Worms: light at the end of their burrow; 10 Do we really need to vaccinate all patients with IBD?; Part III: Investigating IBD; 11 Biomarkers in IBD: myth or marvel?; 12 Radiation exposure in IBD: how do we minimize the dangers?; 13 Surveillance colonoscopy in UC: what is the best way to do it?; Part IV: Medical Therapy; 5-ASA; 14 New 5-ASAs for ulcerative colitis: a tiny step or giant stride forward?; 15 Do 5-ASAs prevent cancer?; 16 Why do we still use 5-ASAs in Crohn's disease?; Steroids 17 Steroids in Crohn's disease: do the benefits outweigh the dangers?Immunomodulators; 18 Thioguanine nucleotide measurement: nonadherent, underdosed, shunter, or refractory?; 19 Thiopurines and the sun: what should be done?; 20 Do thiopurines worsen risk and prognosis of cervical neoplasia?; 21 Optimizing use of methotrexate; 22 Which calcineurin inhibitor and when?; Biologics; 23 Are all anti-TNF agents the same?; 24 One drug or two: do patients on biologics need concurrent immunomodulation?; 25 How do we identify patients needing early aggressive therapy and what should we use? 26 What is the role of biologics in UC?27 What can we do with Crohn's patients who fail or lose response to anti-TNF therapy?; 28 Which extraintestinal manifestations of IBD respond to biologics?; 29 Use and abuse of biologics in pregnancy; 30 Is anti-TNF therapy safe to use in people with a history of malignancy?; 31 The risks of immunomodulators and biologics: what should we tell patients?; 32 When, how, and in whom should we stop biologics?; Part V: Other Treatments; 33 Avoiding drug interactions 34 Is there still a role for ursodeoxycholic acid treatment patients with inflammatory bowel disease associated with primary sclerosing cholangitis?35 Stem cell transplantation for Crohn's: will it fulfill its promise?; 36 Complementary therapy: is there a needle in the haystack?; Part VI: Surgical Dilemmas in IBD; 37 Optimizing IBD patients for surgery and recovery; 38 Is surgery the best initial treatment for limited ileocecal Crohn's disease?; 39 Laparoscopic or open surgery for IBD?; 40 Optimizing management of perianal Crohn's disease 41 Does anti-TNF therapy increase the risk of complications of surgery? |
| Record Nr. | UNINA-9910139555703321 |
Irving Peter
|
||
| Hoboken, : Wiley, 2011 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Clinical dilemmas in inflammatory bowel disease [[electronic resource] /] / edited by Peter Irving, David Rampton, Fergus Shanahan
| Clinical dilemmas in inflammatory bowel disease [[electronic resource] /] / edited by Peter Irving, David Rampton, Fergus Shanahan |
| Pubbl/distr/stampa | Malden, MA, : Blackwell Pub. Ltd, 2006 |
| Descrizione fisica | 1 online resource (264 p.) |
| Disciplina | 616.344 |
| Altri autori (Persone) |
IrvingPeter <1970->
RamptonDavid ShanahanFergus |
| Soggetto topico |
Inflammatory bowel diseases
Inflammatory bowel diseases - Decision making |
| ISBN |
1-281-32207-5
9786611322076 0-470-75082-0 0-470-75028-6 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Clinical Dilemmas in: Inflammatory Bowel Disease; Contents; List of Contributors; Preface; Part 1 Investigating IBD in the 21st Century; 1 Capsule endoscopy: do we need it?; 2 Pathology reports - pitfalls for the unwary; 3 Non-invasive diagnosis and assessment; 4 What is the best way to image perianal Crohn's disease?; 5 Surveillance colonoscopy in UC: alternatives and ways to improve outcome; 6 Abnormal liver tests - what should we do about them?; Part 2 Medical Treatment: Making the Most of What We've Got - 5-ASA drugs; 5-ASA drugs; 7 Is monitoring necessary?
8 Do they have a role in Crohn's disease?Steroids; 9 Steroids in Crohn's: are they obsolete?; Antibiotics for Crohn's disease; 10 Antibiotics: which, when, and for how long?; 11 M ycobacterium av ium paratuberculosis in Crohn's disease: player or spectator?; Immunomodulators; 12 TPMT testing: is it essential?; 13 6-Mercaptopurine or azathioprine?; 14 Thiopurines: how long should we use them for?; 15 Making the most of methotrexate; 16 Cyclosporine: balancing risk and benefit; Infliximab; 17 Contraindications - absolute or relative?; 18 How can we prevent tuberculosis? 19 Dealing with infusion reactions20 Use in ulcerative colitis; 21 Infliximab and surgery: health or hazard?; Nutritional therapy for Crohn's disease; 22 Nutritional therapy for Crohn's disease: is it for adults?; Part 3 Medical Treatment: What's Round the Corner?; 23 Trials and tribulations - interpreting clinical trials in IBD; 24 Genetics - clinical and therapeutic applications; 25 Probiotics - separating science from snakeoil; 26 Worms; 27 Smoking and nicotine - poison for Crohn's, potion for colitis?; 28 Heparin; 29 Leukocytapheresis: filtering out the facts 30 Appendectomy for ulcerative colitis - a therapeutic option?31 Biologic treatments in IBD; 32 Stem cell transplantation for IBD; 33 Complementary and alternative therapy - the way forward or a step back?; Part 4 Common Clinical Challenges: Beyond the Text Book; 34 Functional problems; 35 Psychological stress: something to worry about?; 36 Drugs to avoid; 37 NSAIDs and COX-2 selective agents: cause or cure of pain in IBD?; 38 Iron replacement - is it safe and effective?; 39 Hepatitis B and C viruses - how do they affect management of IBD?; 40 Pregnancy: what drugs can we use? 41 How to prevent growth failure in children42 Predicting outcome in severe UC; 43 Refractory proctitis; 44 CMV co-infection - does it matter?; 45 Treatment of oral Crohn's disease; 46 Pathophysiologic approach to treatment of diarrhea in Crohn's disease; 47 Short bowel; 48 Management of internal fistulae; 49 What is indeterminate colitis?; 50 Pouches for indeterminate colitis?; 51 Colitis-associated cancer: what's the risk to your patients?; 52 What to do with dysplasia, DALMs, and adenomas; Part 5 Managing IBD Outside the Gut; 53 Pyoderma gangrenosum 54 Arthritides - helping the joints without harming the gut |
| Record Nr. | UNINA-9910784972003321 |
| Malden, MA, : Blackwell Pub. Ltd, 2006 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Clinical dilemmas in inflammatory bowel disease [[electronic resource] /] / edited by Peter Irving, David Rampton, Fergus Shanahan
| Clinical dilemmas in inflammatory bowel disease [[electronic resource] /] / edited by Peter Irving, David Rampton, Fergus Shanahan |
| Edizione | [1st ed.] |
| Pubbl/distr/stampa | Malden, MA, : Blackwell Pub. Ltd, 2006 |
| Descrizione fisica | 1 online resource (264 p.) |
| Disciplina | 616.344 |
| Altri autori (Persone) |
IrvingPeter <1970->
RamptonDavid ShanahanFergus |
| Soggetto topico |
Inflammatory bowel diseases
Inflammatory bowel diseases - Decision making |
| ISBN |
1-281-32207-5
9786611322076 0-470-75082-0 0-470-75028-6 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Clinical Dilemmas in: Inflammatory Bowel Disease; Contents; List of Contributors; Preface; Part 1 Investigating IBD in the 21st Century; 1 Capsule endoscopy: do we need it?; 2 Pathology reports - pitfalls for the unwary; 3 Non-invasive diagnosis and assessment; 4 What is the best way to image perianal Crohn's disease?; 5 Surveillance colonoscopy in UC: alternatives and ways to improve outcome; 6 Abnormal liver tests - what should we do about them?; Part 2 Medical Treatment: Making the Most of What We've Got - 5-ASA drugs; 5-ASA drugs; 7 Is monitoring necessary?
8 Do they have a role in Crohn's disease?Steroids; 9 Steroids in Crohn's: are they obsolete?; Antibiotics for Crohn's disease; 10 Antibiotics: which, when, and for how long?; 11 M ycobacterium av ium paratuberculosis in Crohn's disease: player or spectator?; Immunomodulators; 12 TPMT testing: is it essential?; 13 6-Mercaptopurine or azathioprine?; 14 Thiopurines: how long should we use them for?; 15 Making the most of methotrexate; 16 Cyclosporine: balancing risk and benefit; Infliximab; 17 Contraindications - absolute or relative?; 18 How can we prevent tuberculosis? 19 Dealing with infusion reactions20 Use in ulcerative colitis; 21 Infliximab and surgery: health or hazard?; Nutritional therapy for Crohn's disease; 22 Nutritional therapy for Crohn's disease: is it for adults?; Part 3 Medical Treatment: What's Round the Corner?; 23 Trials and tribulations - interpreting clinical trials in IBD; 24 Genetics - clinical and therapeutic applications; 25 Probiotics - separating science from snakeoil; 26 Worms; 27 Smoking and nicotine - poison for Crohn's, potion for colitis?; 28 Heparin; 29 Leukocytapheresis: filtering out the facts 30 Appendectomy for ulcerative colitis - a therapeutic option?31 Biologic treatments in IBD; 32 Stem cell transplantation for IBD; 33 Complementary and alternative therapy - the way forward or a step back?; Part 4 Common Clinical Challenges: Beyond the Text Book; 34 Functional problems; 35 Psychological stress: something to worry about?; 36 Drugs to avoid; 37 NSAIDs and COX-2 selective agents: cause or cure of pain in IBD?; 38 Iron replacement - is it safe and effective?; 39 Hepatitis B and C viruses - how do they affect management of IBD?; 40 Pregnancy: what drugs can we use? 41 How to prevent growth failure in children42 Predicting outcome in severe UC; 43 Refractory proctitis; 44 CMV co-infection - does it matter?; 45 Treatment of oral Crohn's disease; 46 Pathophysiologic approach to treatment of diarrhea in Crohn's disease; 47 Short bowel; 48 Management of internal fistulae; 49 What is indeterminate colitis?; 50 Pouches for indeterminate colitis?; 51 Colitis-associated cancer: what's the risk to your patients?; 52 What to do with dysplasia, DALMs, and adenomas; Part 5 Managing IBD Outside the Gut; 53 Pyoderma gangrenosum 54 Arthritides - helping the joints without harming the gut |
| Record Nr. | UNINA-9910825090603321 |
| Malden, MA, : Blackwell Pub. Ltd, 2006 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Clinical dilemmas in inflammatory bowel disease [[electronic resource] /] / edited by Peter Irving, David Rampton, Fergus Shanahan
| Clinical dilemmas in inflammatory bowel disease [[electronic resource] /] / edited by Peter Irving, David Rampton, Fergus Shanahan |
| Edizione | [1st ed.] |
| Pubbl/distr/stampa | Malden, MA, : Blackwell Pub. Ltd, 2006 |
| Descrizione fisica | 1 online resource (264 p.) |
| Disciplina | 616.344 |
| Altri autori (Persone) |
IrvingPeter <1970->
RamptonDavid ShanahanFergus |
| Soggetto topico |
Inflammatory bowel diseases
Inflammatory bowel diseases - Decision making |
| ISBN |
1-281-32207-5
9786611322076 0-470-75082-0 0-470-75028-6 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Clinical Dilemmas in: Inflammatory Bowel Disease; Contents; List of Contributors; Preface; Part 1 Investigating IBD in the 21st Century; 1 Capsule endoscopy: do we need it?; 2 Pathology reports - pitfalls for the unwary; 3 Non-invasive diagnosis and assessment; 4 What is the best way to image perianal Crohn's disease?; 5 Surveillance colonoscopy in UC: alternatives and ways to improve outcome; 6 Abnormal liver tests - what should we do about them?; Part 2 Medical Treatment: Making the Most of What We've Got - 5-ASA drugs; 5-ASA drugs; 7 Is monitoring necessary?
8 Do they have a role in Crohn's disease?Steroids; 9 Steroids in Crohn's: are they obsolete?; Antibiotics for Crohn's disease; 10 Antibiotics: which, when, and for how long?; 11 M ycobacterium av ium paratuberculosis in Crohn's disease: player or spectator?; Immunomodulators; 12 TPMT testing: is it essential?; 13 6-Mercaptopurine or azathioprine?; 14 Thiopurines: how long should we use them for?; 15 Making the most of methotrexate; 16 Cyclosporine: balancing risk and benefit; Infliximab; 17 Contraindications - absolute or relative?; 18 How can we prevent tuberculosis? 19 Dealing with infusion reactions20 Use in ulcerative colitis; 21 Infliximab and surgery: health or hazard?; Nutritional therapy for Crohn's disease; 22 Nutritional therapy for Crohn's disease: is it for adults?; Part 3 Medical Treatment: What's Round the Corner?; 23 Trials and tribulations - interpreting clinical trials in IBD; 24 Genetics - clinical and therapeutic applications; 25 Probiotics - separating science from snakeoil; 26 Worms; 27 Smoking and nicotine - poison for Crohn's, potion for colitis?; 28 Heparin; 29 Leukocytapheresis: filtering out the facts 30 Appendectomy for ulcerative colitis - a therapeutic option?31 Biologic treatments in IBD; 32 Stem cell transplantation for IBD; 33 Complementary and alternative therapy - the way forward or a step back?; Part 4 Common Clinical Challenges: Beyond the Text Book; 34 Functional problems; 35 Psychological stress: something to worry about?; 36 Drugs to avoid; 37 NSAIDs and COX-2 selective agents: cause or cure of pain in IBD?; 38 Iron replacement - is it safe and effective?; 39 Hepatitis B and C viruses - how do they affect management of IBD?; 40 Pregnancy: what drugs can we use? 41 How to prevent growth failure in children42 Predicting outcome in severe UC; 43 Refractory proctitis; 44 CMV co-infection - does it matter?; 45 Treatment of oral Crohn's disease; 46 Pathophysiologic approach to treatment of diarrhea in Crohn's disease; 47 Short bowel; 48 Management of internal fistulae; 49 What is indeterminate colitis?; 50 Pouches for indeterminate colitis?; 51 Colitis-associated cancer: what's the risk to your patients?; 52 What to do with dysplasia, DALMs, and adenomas; Part 5 Managing IBD Outside the Gut; 53 Pyoderma gangrenosum 54 Arthritides - helping the joints without harming the gut |
| Record Nr. | UNISA-996201971203316 |
| Malden, MA, : Blackwell Pub. Ltd, 2006 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. di Salerno | ||
| ||
Vladimir Nabokov et la France / / Yannicke Chupin, Agnès Edel-Roy, Monica Manolescu, Lara Delage-Toriel
| Vladimir Nabokov et la France / / Yannicke Chupin, Agnès Edel-Roy, Monica Manolescu, Lara Delage-Toriel |
| Autore | Bintein Bénédicte |
| Pubbl/distr/stampa | Strasbourg, : Presses universitaires de Strasbourg, 2018 |
| Descrizione fisica | 1 online resource (248 p.) |
| Altri autori (Persone) |
BoydBrian
ChupinYannicke ConnollyJulian W Delage-TorielLara DurantayeLeland de la Edel-RoyAgnès EellsEmily GassinAlexia GrantPaul LafontAnne-Marie Loison-CharlesJulie ManolescuMonica OlsenLance PoulinIsabelle RamptonDavid SchumanSamuel ShvabrinStanislav SweeneySusan Elizabeth WoodMichael ZhulinaAlisa |
| Collana | Études anglophones |
| Soggetto topico |
Literature
cosmopolitisme intertextualité plurilinguisme littérature intertextuality literature French |
| Soggetto non controllato |
intertextuality
literature French |
| ISBN | 979-1-03-440478-0 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | fre |
| Record Nr. | UNINA-9910495716003321 |
|
Bintein Bénédicte
|
||
| Strasbourg, : Presses universitaires de Strasbourg, 2018 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||